Yuyu Pharma, Inc. Statistics
Want to see KR:000220 full AI Analyst Report?
Yuyu Pharma, Inc. (000220) Stock Statistics & Valuation Metrics
Total Valuation
Yuyu Pharma, Inc. has a market cap or net worth of KRW 54.09B. The enterprise value is KRW 76.23B.
- Market Cap
- KRW 54.09B
- Enterprise Value
- KRW 76.23B
Share Statistics
Yuyu Pharma, Inc. has 15,747,462 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 15,747,462
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Yuyu Pharma, Inc.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 6.02%.
- Return on Equity (ROE)
- 0.06
- Return on Assets (ROA)
- 0.04
- Return on Invested Capital (ROIC)
- 6.02%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 568.08M
- Profits Per Employee
- 32.88M
- Employee Count
- 248
- Asset Turnover
- 0.68
- Inventory Turnover
- 2.06
Valuation Ratios
The current PE Ratio of Yuyu Pharma, Inc. is 5.34. Yuyu Pharma, Inc.’s PEG ratio is 0.06.
- PE Ratio
- 5.34
- PS Ratio
- 0.41
- PB Ratio
- 0.43
- Price to FCF
- 15.03
- Price to Operating Cash Flow
- 2.41
- PEG Ratio
- 0.06
Income Statement
In the last 12 months, Yuyu Pharma, Inc. had revenue of 140.88B and earned 8.15B in profits. Earnings per share was 492.00.
- Revenue
- 140.88B
- Gross Profit
- 53.94B
- Operating Income
- 11.02B
- Pretax Income
- 9.48B
- Net Income
- 8.15B
- EBITDA
- 16.63B
- Earnings Per Share (EPS)
- 492.00
Cash Flow
In the last 12 months, operating cash flow was 24.19B and capital expenditures -20.30B, giving a free cash flow of 3.88B billion.
- Operating Cash Flow
- 24.19B
- Free Cash Flow
- 3.88B
- Free Cash Flow per Share
- 246.45
Dividends & Yields
Yuyu Pharma, Inc. pays an annual dividend of ―, resulting in a dividend yield of 3.10%
- Dividend Per Share
- ―
- Dividend Yield
- 3.10%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 6.65%
- Earnings Yield
- 19.48%
Stock Price Statistics
- Beta
- 0.11
- 52-Week Price Change
- -12.10%
- 50-Day Moving Average
- 3750.40
- 200-Day Moving Average
- 3945.78
- Relative Strength Index (RSI)
- 46.49
- Average Volume (3m)
- 106.06K
Important Dates
Yuyu Pharma, Inc. upcoming earnings date is Mar 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 16, 2026
- Next Earnings Date
- Mar 24, 2027
- Ex-Dividend Date
- ―
Financial Position
Yuyu Pharma, Inc. as a current ratio of 1.64, with Debt / Equity ratio of 21.60%
- Current Ratio
- 1.64
- Quick Ratio
- 0.93
- Debt to Market Cap
- 0.36
- Net Debt to EBITDA
- -0.07
- Interest Coverage Ratio
- 1.98
Taxes
In the past 12 months, Yuyu Pharma, Inc. has paid 365.96M in taxes.
- Income Tax
- 365.96M
- Effective Tax Rate
- 0.04
Enterprise Valuation
Yuyu Pharma, Inc. EV to EBITDA ratio is 8.72, with an EV/FCF ratio of 16.96.
- EV to Sales
- 0.46
- EV to EBITDA
- 8.72
- EV to Free Cash Flow
- 16.96
- EV to Operating Cash Flow
- 2.72
Balance Sheet
Yuyu Pharma, Inc. has KRW 30.03B in cash and marketable securities with KRW 34.47B in debt, giving a net cash position of -KRW 4.44B billion.
- Cash & Marketable Securities
- KRW 30.03B
- Total Debt
- KRW 34.47B
- Net Cash
- -KRW 4.44B
- Net Cash Per Share
- -KRW 282.15
- Tangible Book Value Per Share
- KRW 9,245.18
Margins
Gross margin is 37.73%, with operating margin of 7.97%, and net profit margin of 7.92%.
- Gross Margin
- 37.73%
- Operating Margin
- 7.97%
- Pretax Margin
- 7.69%
- Net Profit Margin
- 7.92%
- EBITDA Margin
- 5.26%
- EBIT Margin
- 1.29%
Analyst Forecast
The average price target for Yuyu Pharma, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 2.90%
- EPS Growth Forecast
- 128.65%
Scores
- Smart Score
- ―
- AI Score
- 67

